Terkko Navigator / Multiple Sclerosis

Mesenchymal stem cells as treatment for MS - progress to date

Clinical relevance of serum natalizumab concentration and anti-natalizumab antibodies in multiple sclerosis

Improved ability to work after one year of natalizumab treatment in multiple sclerosis. Analysis of disease-specific and work-related factors that influence the effect of treatment

Retinol levels are associated with magnetic resonance imaging outcomes in multiple sclerosis

Prominent brainstem and cerebellar involvement in multiple sclerosis with psoriasis

Herpesviruses and human endogenous retroviral sequences in the cerebrospinal fluid of multiple sclerosis patients

Brain activation patterns elicited by the `Faces Symbol Test' -- a pilot fMRI study

Pooled historical MRI data as a basis for research in multiple sclerosis - a statistical evaluation

Editorial